TY  - JOUR
IS  - 6
N2  - Modern Treatment of Chronic Heart Failure This article delves into the contemporary approaches to managing chronic heart failure (CHF), highlighting significant advancements in both medical and non-medical treatments. It covers:

Pharmacological Therapies: Key drugs such as ACE inhibitors, ARBs, beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors, which play crucial roles in improving heart function and patient outcomes.
Device-Based Therapies: Technologies like Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT) devices that assist in regulating heart rhythm and improving cardiac efficiency.
Advanced Therapies: The use of Left Ventricular Assist Devices (LVADs) and heart transplantation for patients with severe heart failure, offering life-extending options.
Lifestyle Modifications: The importance of diet, exercise, patient education, and self-management in controlling symptoms and improving quality of life.
Emerging Therapies: Innovations in gene therapy, regenerative medicine, and novel pharmacological agents that hold promise for future treatments.

The article underscores the multifaceted nature of CHF treatment, combining established methods with cutting-edge research to enhance patient care and outcomes.
TI  - MODERN TREATMENT OF CHRONIC HEART FAILURE: INNOVATIONS AND APPROACHES
SN  - 3030-3001
KW  - Chronic Heart Failure (CHF)
KW  -  - Pharmacological Therapies
KW  -   ACE
KW  -  Inhibitors
KW  -   ARBs (Angiotensin II Receptor Blockers)
KW  -   Beta-Blockers
KW  -   Mineralocorticoid Receptor Antagonists
KW  -   SGLT2 Inhibitors
KW  -   Device-Based Therapies
KW  -   Implantable Cardioverter Defibrillators (ICDs)
KW  -   Cardiac Resynchronization Therapy (CRT)
KW  -    Left Ventricular Assist Devices (LVADs)
KW  -   Heart Transplantation
KW  -    Lifestyle Modifications
KW  -   Patient Education
KW  -   Gene Therapy
KW  -   Regenerative Medicine
KW  -   Novel Pharmacological Agents
KW  -   Heart Function
KW  -   Quality of Life.
JF  - MEDICINE, PEDAGOGY AND TECHNOLOGY: THEORY AND PRACTICE
EP  - 379
ID  - arxiv103885
UR  - https://universalpublishings.com/index.php/mpttp/article/view/6453
A1  - Shakhzodbek Yormatov, Shakhzodbek Yormatov
A1  - Rustamov Yusufjon Rustam o'g'li, Rustamov Yusufjon Rustam o'g'li
SP  - 374
VL  - 2
Y1  - 2024/06/24/
AV  - public
ER  -